Scott H. James

1.9k total citations
39 papers, 885 citations indexed

About

Scott H. James is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Scott H. James has authored 39 papers receiving a total of 885 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Epidemiology, 14 papers in Infectious Diseases and 5 papers in Surgery. Recurrent topics in Scott H. James's work include Cytomegalovirus and herpesvirus research (24 papers), Herpesvirus Infections and Treatments (14 papers) and Parvovirus B19 Infection Studies (6 papers). Scott H. James is often cited by papers focused on Cytomegalovirus and herpesvirus research (24 papers), Herpesvirus Infections and Treatments (14 papers) and Parvovirus B19 Infection Studies (6 papers). Scott H. James collaborates with scholars based in United States, Ukraine and United Kingdom. Scott H. James's co-authors include David W. Kimberlin, Mark N. Prichard, Richard J. Whitley, Jeanne S. Sheffield, Caroll B. Hartline, Richard Lyon, Gareth Clegg, Holly P. Branigan, Swetha Pinninti and Ellen Gurman Bard and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and The Journal of Infectious Diseases.

In The Last Decade

Scott H. James

36 papers receiving 864 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott H. James United States 16 602 228 91 91 87 39 885
Sébastien Hantz France 17 583 1.0× 277 1.2× 56 0.6× 62 0.7× 73 0.8× 75 873
Nathalie Goyette Canada 20 1.1k 1.8× 246 1.1× 32 0.4× 104 1.1× 142 1.6× 48 1.3k
Jeanine Bartlett United States 14 441 0.7× 530 2.3× 39 0.4× 173 1.9× 158 1.8× 26 1.2k
Eddie Louie United States 12 621 1.0× 467 2.0× 19 0.2× 53 0.6× 57 0.7× 25 908
David Shasha Israel 13 157 0.3× 213 0.9× 36 0.4× 85 0.9× 64 0.7× 27 481
D. Meillet France 17 185 0.3× 217 1.0× 46 0.5× 121 1.3× 96 1.1× 47 703
Wolfgang Poeppl Austria 19 344 0.6× 332 1.5× 24 0.3× 83 0.9× 140 1.6× 61 1.0k
Marie‐Christine Mazeron France 21 831 1.4× 193 0.8× 47 0.5× 137 1.5× 84 1.0× 53 1.1k
Christophe Michon France 14 356 0.6× 505 2.2× 63 0.7× 98 1.1× 244 2.8× 32 1.1k
J. Ives United Kingdom 9 1.0k 1.7× 211 0.9× 20 0.2× 76 0.8× 178 2.0× 10 1.1k

Countries citing papers authored by Scott H. James

Since Specialization
Citations

This map shows the geographic impact of Scott H. James's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott H. James with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott H. James more than expected).

Fields of papers citing papers by Scott H. James

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott H. James. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott H. James. The network helps show where Scott H. James may publish in the future.

Co-authorship network of co-authors of Scott H. James

This figure shows the co-authorship network connecting the top 25 collaborators of Scott H. James. A scholar is included among the top collaborators of Scott H. James based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott H. James. Scott H. James is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Willis, Zachary, Mari Nakamura, Joshua Wolf, et al.. (2024). Risk Factors for Pediatric Critical COVID-19: A Systematic Review and Meta-Analysis. Journal of the Pediatric Infectious Diseases Society. 13(7). 352–362. 6 indexed citations
2.
Keith, Kathy A., et al.. (2024). A ProTide of AZT Shows Activity Against Human Papillomaviruses. ChemMedChem. 19(8). e202300661–e202300661.
3.
Myers, Angela, Scott H. James, Joshua R. Watson, Sylvia H. Yeh, & Kristina A. Bryant. (2023). Averting a Crisis: Innovating Pediatric Infectious Diseases Recruitment and Training. Journal of the Pediatric Infectious Diseases Society. 12(11). 559–563. 4 indexed citations
4.
Shablykin, Oleh, Kathy A. Keith, Emma A. Harden, et al.. (2023). In vitro activity of novel 4-iminohydantoin sulfamide derivatives against human cytomegalovirus. Chemical Papers. 78(1). 133–140. 2 indexed citations
5.
Pinninti, Swetha, Camden L. Hebson, Sushma Boppana, et al.. (2023). Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Variants on Short- and Mid-term Cardiac Outcomes in Multisystem Inflammatory Syndrome in Children. Open Forum Infectious Diseases. 10(1). ofad009–ofad009. 1 indexed citations
6.
Gardner, Thomas J., Steven M. Kwasny, Steven C. Cardinale, et al.. (2022). Investigating N-arylpyrimidinamine (NAPA) compounds as early-stage inhibitors against human cytomegalovirus. Antiviral Research. 209. 105474–105474. 3 indexed citations
7.
Kovalishyn, Vasyl, Kathy A. Keith, Emma A. Harden, et al.. (2021). Design of new imidazole derivatives with anti-HCMV activity: QSAR modeling, synthesis and biological testing. Journal of Computer-Aided Molecular Design. 35(12). 1177–1187. 11 indexed citations
8.
James, Scott H., et al.. (2021). Neonatal Herpes Simplex Virus Disease. Clinics in Perinatology. 48(2). 263–274. 29 indexed citations
9.
Pinninti, Swetha, et al.. (2020). Rhabdomyolysis and Acute Renal Failure in an Adolescent With Coronavirus Disease 2019. Journal of the Pediatric Infectious Diseases Society. 9(4). 507–509. 25 indexed citations
10.
James, Scott H., et al.. (2020). Prevention and treatment of neonatal herpes simplex virus infection. Antiviral Research. 176. 104721–104721. 24 indexed citations
11.
James, Scott H., et al.. (2018). Antiviral Therapies for Herpesviruses: Current Agents and New Directions. Clinical Therapeutics. 40(8). 1282–1298. 102 indexed citations
12.
James, Scott H. & David W. Kimberlin. (2015). Advances in the prevention and treatment of congenital cytomegalovirus infection. Current Opinion in Pediatrics. 28(1). 81–85. 48 indexed citations
13.
James, Scott H. & David W. Kimberlin. (2015). Neonatal Herpes Simplex Virus Infection. Infectious Disease Clinics of North America. 29(3). 391–400. 73 indexed citations
14.
James, Scott H. & David W. Kimberlin. (2014). Neonatal Herpes Simplex Virus Infection. Clinics in Perinatology. 42(1). 47–59. 89 indexed citations
15.
James, Scott H. & Mark N. Prichard. (2014). Current and future therapies for herpes simplex virus infections: mechanism of action and drug resistance. Current Opinion in Virology. 8. 54–61. 87 indexed citations
16.
17.
James, Scott H., Nathan Price, Caroll B. Hartline, E. Randall Lanier, & Mark N. Prichard. (2013). Selection and Recombinant Phenotyping of a Novel CMX001 and Cidofovir Resistance Mutation in Human Cytomegalovirus. Antimicrobial Agents and Chemotherapy. 57(7). 3321–3325. 26 indexed citations
18.
Prichard, Mark N., Caroll B. Hartline, Rachel Gill, Terry L. Bowlin, & Scott H. James. (2011). Cyclopropavir Inhibits the Normal Function of the Human Cytomegalovirus UL97 Kinase. Antiviral Research. 90(2). A24–A24. 1 indexed citations
19.
James, Scott H., David W. Kimberlin, & Richard J. Whitley. (2009). Antiviral therapy for herpesvirus central nervous system infections: Neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection. Antiviral Research. 83(3). 207–213. 71 indexed citations
20.
James, Scott H., et al.. (2009). Healthcare Worker Knowledge of Measurement and Documentation of Tuberculin Skin Test Reaction. Infection Control and Hospital Epidemiology. 30(12). 1230–1232. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sébastien Hantz Breakdown of academic impact, for papers by Nathalie Goyette Breakdown of academic impact, for papers by Jeanine Bartlett Breakdown of academic impact, for papers by Eddie Louie Breakdown of academic impact, for papers by David Shasha Breakdown of academic impact, for papers by D. Meillet Breakdown of academic impact, for papers by Wolfgang Poeppl Breakdown of academic impact, for papers by Marie‐Christine Mazeron Breakdown of academic impact, for papers by Christophe Michon Breakdown of academic impact, for papers by J. Ives
Rankless by CCL
2026